FORMULATION RESEARCH
Selected medicinal plants and other formulation components are evaluated within the context of their intended role, available scientific research and the broader design of the relevant SinaVita® system.
Selected medicinal plants and other formulation components are evaluated within the context of their intended role, available scientific research and the broader design of the relevant SinaVita® system.
Matricaria Chamomilla is included within selected components as part of the structured formulation, chosen for its compatibility and role within the overall system design.
Eucalyptus Globulus is included within selected components as part of the structured formulation, chosen for its compatibility and role within the overall system design.
Nigella Sativa is included within selected components as part of the structured formulation, chosen for its compatibility and role within the overall system design.
Tanacetum Parthenium is included within selected components as part of the structured formulation, chosen for its compatibility and role within the overall system design.
Lavandula Officinalis is included within selected components as part of the structured formulation, chosen for its compatibility and role within the overall system design.
01
Different components and formats are brought together around clearly defined roles within each system.
02
Clear directions and structured routines designed to make consistent use easier.
03
Safety considerations are integrated throughout product development and evaluation.
04
Ingredients, formats and components are selected with a defined purpose within the broader system.
Part of SinaVita®’s research heritage originates from earlier migraine research programs developed by MIM Pharma. This work was shared within the professional headache research community, including presentation at the 60th Annual Scientific Meeting of the American Headache Society in 2018 — an international forum for headache and migraine research.
These development insights contributed to the broader thinking behind today’s structured, multi-format SinaVita® approach.
Earlier formulation development included acute toxicological assessment.
Repeated-exposure assessment formed part of earlier preclinical development.
Safety parameters were evaluated under defined study conditions
Major organs were examined histologically as part of earlier preclinical formulation development.
RESEARCH-INFORMED. PURPOSEFULLY DEVELOPED
SinaVita® combines research-informed development, defined formulation principles and structured system design across its health support categories. Evidence and regulatory requirements are considered according to the individual product, formulation and applicable product category.